Latest filing published 09 Jul 2026 for Arcus Biosciences, Inc., €655k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of Juan Jaen in Arcus Biosciences, Inc. In total, 3 filings cover trades dated from 22 June 2026 to 9 July 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 9 July 2026, the filings show a transaction worth €655k in Arcus Biosciences, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations